Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - Evelo Biosciences, Inc. | a12312019exhibit312.htm |
| EX-32.2 - EXHIBIT 32.2 - Evelo Biosciences, Inc. | a12312019exhibit322.htm |
| EX-32.1 - EXHIBIT 32.1 - Evelo Biosciences, Inc. | a12312019exhibit321.htm |
| EX-31.1 - EXHIBIT 31.1 - Evelo Biosciences, Inc. | a12312019exhibit311.htm |
| EX-21.1 - EXHIBIT 21.1 - Evelo Biosciences, Inc. | a12312019exhibit211.htm |
| EX-10.5 - EXHIBIT 10.5 - Evelo Biosciences, Inc. | a12312019exhibit105.htm |
| EX-10.4 - EXHIBIT 10.4 - Evelo Biosciences, Inc. | a12312019exhibit104.htm |
| EX-10.3 - EXHIBIT 10.3 - Evelo Biosciences, Inc. | a12312019exhibit103.htm |
| EX-4.3 - EXHIBIT 4.3 - Evelo Biosciences, Inc. | a12312019exhibit43.htm |
| 10-K - FORM 10-K - Evelo Biosciences, Inc. | evelo10-k12312019.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the Registration Statements:
(1) | Registration Statement (Form S-3 No. 333-231911) of Evelo Biosciences, Inc., and |
(2) | Registration Statement (Form S-8 No. 333-224841) of Evelo Biosciences, Inc. |
of our report dated February 14, 2020, with respect to the consolidated financial statements of Evelo Biosciences, Inc. included in this Annual Report (Form 10-K) of Evelo Biosciences, Inc. for the year ended December 31, 2019.
/s/ Ernst & Young LLP
Boston, MA
February 14, 2020